Adam Kern

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Atrial Fibrillation

Percutaneous Coronary Intervention

Patients Undergoing

Prognostic Factors

Top Venues

Journal of personalized medicine

Journal of cardiovascular development and disease

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Rakesh Jalali, Jacek Zwiernik, Ewa Rotkiewicz, Beata Zwiernik, Adam Kern, Jacek Bil, Anita Jalali, Joanna Manta, Jerzy Romaszko
Predicting Short- and Long-Term Functional Outcomes Based on Serum S100B Protein Levels in Patients with Ischemic Stroke. Journal of personalized medicine 14 (1) (2024)
Rakesh Jalali, Jacek Zwiernik, Ewa Rotkiewicz, Beata Zwiernik, Adam Kern, Jacek Bil, Anita Jalali, Joanna Manta, Jerzy Romaszko
Predicting Short- and Long-Term Functional Outcomes Based on Serum S100B Protein Levels in Patients with Ischemic Stroke. Journal of personalized medicine 14 (1) (2024)
Jacek Bil, Maciej Tyczynski, Adam Kern, Krystian Bojko, Robert J Gil
Percutaneous Coronary Interventions with Sirolimus-Eluting Alex Plus Stents in Patients with or without Diabetes: 4-Year Results. Journal of cardiovascular development and disease 11 (6) (2024)
Jacek Bil, Maciej Tyczynski, Adam Kern, Krystian Bojko, Robert J Gil
Percutaneous Coronary Interventions with Sirolimus-Eluting Alex Plus Stents in Patients with or without Diabetes: 4-Year Results. Journal of cardiovascular development and disease 11 (6) (2024)
Jacek Bil, Maciej Tyczynski, Adam Kern, Krystian Bojko, Robert J Gil
Percutaneous Coronary Interventions with Sirolimus-Eluting Alex Plus Stents in Patients with or without Diabetes: 4-Year Results. Journal of cardiovascular development and disease 11 (6) (2024)
Robert J Gil, Adam Kern, Krystian Bojko, Aneta Gziut-Rudkowska, Dobrin Vassilev, Jacek Bil
The Randomized, Multicenter, Open-Label, Controlled POLBOS 3 Trial Comparing Regular Drug-Eluting Stents and the Sirolimus-Eluting BiOSS LIM C Dedicated Coronary Bifurcation Stent: Four-Year Results. Biomedicines 12 (5) (2024)
Robert J Gil, Adam Kern, Krystian Bojko, Aneta Gziut-Rudkowska, Dobrin Vassilev, Jacek Bil
The Randomized, Multicenter, Open-Label, Controlled POLBOS 3 Trial Comparing Regular Drug-Eluting Stents and the Sirolimus-Eluting BiOSS LIM C Dedicated Coronary Bifurcation Stent: Four-Year Results. Biomedicines 12 (5) (2024)
Maciej Tyczyński, Adam Kern, Patryk Buller, Wojciech Wańha, Robert J Gil, Jacek Bil
Clinical Outcomes and Prognostic Factors in Complex, High-Risk Indicated Procedure (CHIP) and High-Bleeding-Risk (HBR) Patients Undergoing Percutaneous Coronary Intervention with Sirolimus-Eluting Stent Implantation: 4-Year Results. Journal of clinical medicine 12 (16) (2023)
Patryk Buller, Adam Kern, Maciej Tyczyński, Wojciech Rosiak, Włodzimierz Figatowski, Robert J Gil, Jacek Bil
The Comparison of Predicting Factors and Outcomes of MINOCA and STEMI Patients in the 5-Year Follow-Up. Journal of personalized medicine 13 (5) (2023)
Adam Kern, Tomasz Stompór, Jolanta Kiewisz, Bartlomiej Emil Krazinski, Jacek Kiezun, Marta Kieżun, Jerzy Górny, Ewa Sienkiewicz, Leszek Gromadziński, Dariusz Onichimowski, Jacek Bil
The Impact of Sclerostin Levels on Long-Term Prognosis in Patients Undergoing Coronary Angiography: A Personalized Approach with 9-Year Follow-Up. Journal of personalized medicine 11 (3) (2021)